Drug Substance Manufacturing Infocard
Summary: Catalent Biologics’ state-of-the-art facilities have been designed to provide integrated bulk drug substance for clinical trials and commercial launches, with options to utilize single-use or stainless-steel bioreactors in a rigorous CGMP environment.